FuGene
Manufacturing · Wisconsin, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1600 Aspen Cmns Ste 101, Middleton, Wisc...Phone Number
(608) 628-7772Website
www.fugene.comRevenue
<$5 MillionIndustry
About FuGene
FuGENE® HD is a next-generation, multi-component transfection reagent designed for the delivery of DNA into more challenging eukaryotic and insect cell lines. FuGENE® HD interacts with nucleic acids to provide efficient and safe entry into the cell, allowing users to overcome barriers in difficult-to-transfect lines such as primary cells, stem cells, and suspension cells. Its simple, easy-to-use protocol allows users to free up valuable lab time. FuGENE® 6 DNA Transfection Reagent is the original, multi-component, lipid-based transfection reagent invented by Fugent LLC. Designed for delivery of DNA of all sizes, it offers high-efficiency transfection with extremely low toxicity in over 800 eukaryotic cell lines. FuGENE® 6 saves time and resources due to minimal reagent preparation, media changes & optimization, and is very cost-effective for budget-conscious labs.Explore more
SIC Code 28,283NAICS Code 32,325Show moreFuGene Org Chart
Compare Similar Companies to FuGene
Compare insights from companies similar to FuGene, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
FuGene Tech Stack
A closer look at the technologies used by FuGene
See more technologies
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding FuGene
Sign Up For FreeTo access detailed company insights
FuGENE® HD is a next-generation, multi-component transfection reagent designed for the delivery of DNA into more challenging eukaryotic and insect cell lines. FuGENE® HD interacts with nucleic acids to provide efficient and safe entry into the cell, allowing users to overcome barriers in difficult-to-transfect lines such as primary cells, stem cell... Read More